Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vivid Vision is a private ophthalmic digital health and medical device company developing virtual reality-based vision testing and therapy products. Its commercial offerings include clinic- and home-based software for amblyopia, strabismus, and convergence insufficiency, as well as Vivid Vision Perimetry and related digital endpoint tools for retinal and glaucoma clinical trials. The company positions its platform across both patient care and biopharma research, using VR to deliver functional vision assessments and therapeutic exercises. Vivid Vision appears to be commercially active, with operations in the United States and Japan and use by providers and patients internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vivid Vision.